Vivo Capital, LLC Astria Therapeutics, Inc. Transaction History
Vivo Capital, LLC
- $683 Million
- Q3 2024
A detailed history of Vivo Capital, LLC transactions in Astria Therapeutics, Inc. stock. As of the latest transaction made, Vivo Capital, LLC holds 1,552,685 shares of ATXS stock, worth $14.4 Million. This represents 2.5% of its overall portfolio holdings.
Number of Shares
1,552,685
Previous 2,329,027
33.33%
Holding current value
$14.4 Million
Previous $21.2 Million
19.34%
% of portfolio
2.5%
Previous 3.13%
Shares
5 transactions
Others Institutions Holding ATXS
# of Institutions
107Shares Held
48.6MCall Options Held
48KPut Options Held
9.3K-
Perceptive Advisors LLC New York, NY6.49MShares$60.2 Million1.87% of portfolio
-
Ra Capital Management, L.P. Boston, MA5.11MShares$47.4 Million0.78% of portfolio
-
Vestal Point Capital, LP New York, NY4MShares$37.2 Million3.34% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA3.55MShares$33 Million6.36% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$32.7 Million0.0% of portfolio
About Astria Therapeutics, Inc.
- Ticker ATXS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 15,178,000
- Market Cap $141M
- Description
- Astria Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare and niche allergic, and immunological diseases in the United States. Its lead product candidate is STAR-0215, a monoclonal antibody inhibitor of plasma kallikrein, which is in preclinical development stage...